EICHORCondition: Colorectal Cancer · Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The FUTURE trial is a prospective, multicentre, exploratory, open-label phase II platform trial. Its goal is to evaluate the efficacy, feasibility and safety of futibatinib combined with immunotherapeutic, targeted or chemotherapeutic agents in colorectal and other solid tumors and to additionally identify biomarkers that correlate with clinical outcome.
This description comes directly from the study's public registry record.
Thorsten O. Götze, Prof. Dr. · 0049 69 7601 · future@ikf-khnw.de
Annika S. Stürzebecher, Dr. · 0049 69 5899 787 · future@ikf-khnw.de
Always discuss trial participation with your own doctor first.
| Klinikum St. Marien Amberg | Amberg, Germany | Not Yet Recruiting |
| Charité Campus Virchow Klinikum (CVK) | Berlin, Germany | Not Yet Recruiting |
| Universitätsklinikum Düsseldorf | Düsseldorf, Germany | Recruiting |
| Kliniken Essen-Mitte | Essen, Germany | Recruiting |
| Krankenhaus Nordwest | Frankfurt am Main, Germany | Recruiting |
| Hope Hamburg | Hamburg, Germany | Recruiting |
| Universitätsmedizin Mainz | Mainz, Germany | Not Yet Recruiting |
| Klinikum München rechts der Isar | München, Germany | Recruiting |
| MVZ für Hämatologie und Onkologie Ravensburg GmbH | Ravensburg, Germany | Not Yet Recruiting |
| Leopoldina Krankenhaus Schweinfurt | Schweinfurt, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06722183